serv meat strong result outlook
invest summari reiter ow rate price
target share post beat rais ahead posit
outlook note call given compani durabl
busi model macro tailwind think multipl hold upward
earn revis drive share higher think multipl
support durabl busi model macro tailwind solid
execut manag upward earn revis could come higher-
than-anticip peak sale new launch better-than-expect oper
margin
posit quarter support thesi
complet acquisit abaxi aggreg
usda grant expand indic cytopoint treatment
allerg atop dermat dog report revenu
growth well histor industri averag mid-singl digit
compani also deliv oper growth revenu oper
growth adjust net incom would note abaxi contribut
quarter companion anim product perform well primarili
base key dermatolog brand new parasiticid addit
abaxi diagnost portfolio simparica trio expect come market
livestock product swine poultri fish portfolio
deliv double-digit growth modest growth cattl
expect recoveri cattl sometim headwind sale
oper expens make tough yoy comparison
reflect model strong cost sale higher vs
four fewer intern calendar day
expect hit high end sg expens guidanc
report ep factset consensu
higher estim increas ep guidanc rang
factset consensu rais
midpoint reflect beat rel consensu updat financi
model increas ep estim
 valuat use blend dcf multipl ev/ebitda analysi get
price target
disclosur section may found page
use blend dcf multipl ev/ebitda analysi get price
target
sever potenti risk posit invest thesi price target
restrict ban use antibacteri food-produc anim may
becom preval zoeti current sell antibacteri product govern
consum begun shift away consum prefer and/or govern
regul grow may affect zoetiss abil meet forecast
advers weather condit avail natur resourc could drive
price feed expens compon produc feed price rise
profit fall zoetiss custom may spend less anim health drug
lack new product launch and/or exist product fail gain market share
street good expect zoetiss new launch compani perform
line better expect could downsid risk number
macro factor weather feed price currenc could advers impact sale
earn zoeti off-set sinc global busi said macro factor
global could pressur earn
oper margin expans lower expect zoeti still gross margin
expans expect compani meet target and/or
margin improv seen to-dat sustain could downsid number
brand and/or gener competit key drug zoeti face competit could
headwind sale given larg number product portfolio compani
strong relationship custom see smaller type risk
bull bear base case analysi
use dcf multipl price-to-earnings analysi arriv bull bear case scenario
base analysi estim likelihood stock worth next
exhibit bull bear base case scenario analysi
cantor fitzgerald research compani reportsbul casenew launch better expectedmargin improv better expectedmacro factor improvestrateg busi scenario casenew launch in-lin expectationsmargin improv in-lin expectationsmacro factor remain stableno busi scenario casenew launch expectationsmargin improv expectationsheadwind macro factor busi scenario exhibit varianc analysi
exhibit catalyst event calendar
amount chang yoyamount chang driven key dermatolog brand acquisit abaxi growth poultri total gross oper oper non oper pre-tax tax net averag cantor fitzgerald research compani reportsactualcantor
exhibit incom statement analysi
exhibit margin analysi
exhibit quarterli sale analysi
exhibit annual sale analysi
exhibit analysi
exhibit balanc sheet analysi
zoeti anim health compani focus discoveri develop manufactur commerci anim health medicin
vaccin across livestock companion anim zoeti directli market product countri product sold
countri world-wide zoeti focuss eight core speci cattl swine poultri sheep fish form part compani
livestock segment dog cat hors manag compani companion anim segment zoetiss five major product
categori within segment anti-infect vaccin parasiticid medic feed addit pharmaceut
